APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Delivery System Technology Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gene Delivery System Technology Drug Industry Growth and Trends Forecast to 2032

2 January 2026102 pages

Choose your research edition.

Industry ResearchGene Delivery System Technology Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Delivery System Technology Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gene Delivery System Technology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Delivery System Technology Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Delivery System Technology Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Gene Delivery System Technology Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gene Delivery System Technology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gene Delivery System Technology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Delivery System Technology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Gene Delivery System Technology Drug market include Akcea Therapeutics, Alnylam Pharmaceuticals, AnGes, bluebird bio, Gilead Sciences, Human Stem Cells Institute, Orchard Therapeutics, Sarepta Therapeutics and SIBIONO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gene Delivery System Technology Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gene Delivery System Technology Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene Delivery System Technology Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene Delivery System Technology Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Gene Delivery System Technology Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gene Delivery System Technology Drug Market by Company

Akcea Therapeutics

Alnylam Pharmaceuticals

AnGes

bluebird bio

Gilead Sciences

Human Stem Cells Institute

Orchard Therapeutics

Sarepta Therapeutics

SIBIONO

Spark Therapeutics

Sunway Biotech

Amgen

Biogen

Novartis

Gene Delivery System Technology Drug Segment by Type

Viral Gene Delivery System

Non-viral Gene Delivery System

Gene Delivery System Technology Drug Segment by Application

Neurological Diseases

Cancer

Other

Gene Delivery System Technology Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Delivery System Technology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Delivery System Technology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Delivery System Technology Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Gene Delivery System Technology Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Gene Delivery System Technology Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Gene Delivery System Technology Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Gene Delivery System Technology Drug Market Share by Region (2021-2026) Table 4. Global Gene Delivery System Technology Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Gene Delivery System Technology Drug Market Share by Region (2027-2032) Table 6. Global Gene Delivery System Technology Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gene Delivery System Technology Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Gene Delivery System Technology Drug Market Size Share by Type (2021-2026) Table 9. Global Gene Delivery System Technology Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Gene Delivery System Technology Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Gene Delivery System Technology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Gene Delivery System Technology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Gene Delivery System Technology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Gene Delivery System Technology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Gene Delivery System Technology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Gene Delivery System Technology Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Gene Delivery System Technology Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Gene Delivery System Technology Drug Market Size Share by Application (2021-2026) Table 24. Global Gene Delivery System Technology Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Gene Delivery System Technology Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Gene Delivery System Technology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Gene Delivery System Technology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Gene Delivery System Technology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Gene Delivery System Technology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Gene Delivery System Technology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Gene Delivery System Technology Drug Industry Trends Table 37. Gene Delivery System Technology Drug Industry Drivers Table 38. Gene Delivery System Technology Drug Industry Opportunities and Challenges Table 39. Gene Delivery System Technology Drug Industry Restraints Table 40. Global Gene Delivery System Technology Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Gene Delivery System Technology Drug Revenue Market Share by Company (2021-2026) Table 42. Global Gene Delivery System Technology Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Gene Delivery System Technology Drug Key Company Headquarters & Area Served Table 44. Global Gene Delivery System Technology Drug Company, Product Type & Application Table 45. Global Gene Delivery System Technology Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Gene Delivery System Technology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Akcea Therapeutics Company Information Table 49. Akcea Therapeutics Business Overview Table 50. Akcea Therapeutics Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Akcea Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 52. Akcea Therapeutics Recent Development Table 53. Alnylam Pharmaceuticals Company Information Table 54. Alnylam Pharmaceuticals Business Overview Table 55. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product Portfolio Table 57. Alnylam Pharmaceuticals Recent Development Table 58. AnGes Company Information Table 59. AnGes Business Overview Table 60. AnGes Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AnGes Gene Delivery System Technology Drug Product Portfolio Table 62. AnGes Recent Development Table 63. bluebird bio Company Information Table 64. bluebird bio Business Overview Table 65. bluebird bio Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. bluebird bio Gene Delivery System Technology Drug Product Portfolio Table 67. bluebird bio Recent Development Table 68. Gilead Sciences Company Information Table 69. Gilead Sciences Business Overview Table 70. Gilead Sciences Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Gilead Sciences Gene Delivery System Technology Drug Product Portfolio Table 72. Gilead Sciences Recent Development Table 73. Human Stem Cells Institute Company Information Table 74. Human Stem Cells Institute Business Overview Table 75. Human Stem Cells Institute Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Human Stem Cells Institute Gene Delivery System Technology Drug Product Portfolio Table 77. Human Stem Cells Institute Recent Development Table 78. Orchard Therapeutics Company Information Table 79. Orchard Therapeutics Business Overview Table 80. Orchard Therapeutics Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Orchard Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 82. Orchard Therapeutics Recent Development Table 83. Sarepta Therapeutics Company Information Table 84. Sarepta Therapeutics Business Overview Table 85. Sarepta Therapeutics Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sarepta Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 87. Sarepta Therapeutics Recent Development Table 88. SIBIONO Company Information Table 89. SIBIONO Business Overview Table 90. SIBIONO Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. SIBIONO Gene Delivery System Technology Drug Product Portfolio Table 92. SIBIONO Recent Development Table 93. Spark Therapeutics Company Information Table 94. Spark Therapeutics Business Overview Table 95. Spark Therapeutics Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Spark Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 97. Spark Therapeutics Recent Development Table 98. Sunway Biotech Company Information Table 99. Sunway Biotech Business Overview Table 100. Sunway Biotech Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sunway Biotech Gene Delivery System Technology Drug Product Portfolio Table 102. Sunway Biotech Recent Development Table 103. Amgen Company Information Table 104. Amgen Business Overview Table 105. Amgen Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Amgen Gene Delivery System Technology Drug Product Portfolio Table 107. Amgen Recent Development Table 108. Biogen Company Information Table 109. Biogen Business Overview Table 110. Biogen Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Biogen Gene Delivery System Technology Drug Product Portfolio Table 112. Biogen Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis Gene Delivery System Technology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Novartis Gene Delivery System Technology Drug Product Portfolio Table 117. Novartis Recent Development Table 118. North America Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Gene Delivery System Technology Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Gene Delivery System Technology Drug Market Share by Country (2021-2026) Table 121. North America Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Gene Delivery System Technology Drug Market Share Forecast by Country (2027-2032) Table 123. Europe Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Gene Delivery System Technology Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Gene Delivery System Technology Drug Market Share by Country (2021-2026) Table 126. Europe Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Gene Delivery System Technology Drug Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Gene Delivery System Technology Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Gene Delivery System Technology Drug Market Share by Country (2021-2026) Table 131. Asia-Pacific Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Gene Delivery System Technology Drug Market Share Forecast by Country (2027-2032) Table 133. Latin America Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Gene Delivery System Technology Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Gene Delivery System Technology Drug Market Share by Country (2021-2026) Table 136. Latin America Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Gene Delivery System Technology Drug Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Gene Delivery System Technology Drug Market Share by Country (2021-2026) Table 141. Middle East & Africa Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Gene Delivery System Technology Drug Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Gene Delivery System Technology Drug Product Image Figure 3. Global Gene Delivery System Technology Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Gene Delivery System Technology Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Gene Delivery System Technology Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Gene Delivery System Technology Drug Market Share by Region (2021-2032) Figure 7. North America Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Viral Gene Delivery System Image Figure 13. Global Viral Gene Delivery System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-viral Gene Delivery System Image Figure 15. Global Non-viral Gene Delivery System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Gene Delivery System Technology Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Gene Delivery System Technology Drug Market Share by Type 2025 VS 2032 Figure 18. North America Gene Delivery System Technology Drug Market Size Share by Type (2021-2032) Figure 19. Europe Gene Delivery System Technology Drug Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Gene Delivery System Technology Drug Market Size Share by Type (2021-2032) Figure 21. Latin America Gene Delivery System Technology Drug Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Gene Delivery System Technology Drug Market Size Share by Type (2021-2032) Figure 23. Neurological Diseases Image Figure 24. Global Neurological Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Cancer Image Figure 26. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Gene Delivery System Technology Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Gene Delivery System Technology Drug Market Share by Application 2025 VS 2032 Figure 31. North America Gene Delivery System Technology Drug Market Size Share by Application (2021-2032) Figure 32. Europe Gene Delivery System Technology Drug Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Gene Delivery System Technology Drug Market Size Share by Application (2021-2032) Figure 34. Latin America Gene Delivery System Technology Drug Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Gene Delivery System Technology Drug Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Gene Delivery System Technology Drug Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Gene Delivery System Technology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Gene Delivery System Technology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Gene Delivery System Technology Drug Market Share by Country (2021-2032) Figure 41. Europe Gene Delivery System Technology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Gene Delivery System Technology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Gene Delivery System Technology Drug Market Share by Country (2021-2032) Figure 44. Asia-Pacific Gene Delivery System Technology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Gene Delivery System Technology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Gene Delivery System Technology Drug Market Share by Country (2021-2032) Figure 47. Latin America Gene Delivery System Technology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Gene Delivery System Technology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Gene Delivery System Technology Drug Market Share by Country (2021-2032) Figure 50. Middle East & Africa Gene Delivery System Technology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Gene Delivery System Technology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Gene Delivery System Technology Drug Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Delivery System
  • Non-viral Gene Delivery System
Applications
  • Neurological Diseases
  • Cancer
  • Other
Companies covered
  • Akcea Therapeutics
  • Alnylam Pharmaceuticals
  • AnGes
  • bluebird bio
  • Gilead Sciences
  • Human Stem Cells Institute
  • Orchard Therapeutics
  • Sarepta Therapeutics
  • SIBIONO
  • Spark Therapeutics
  • Sunway Biotech
  • Amgen
  • Biogen
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Gene Delivery System Technology Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Gene Delivery System Technology Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Gene Delivery System Technology Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Gene Delivery System Technology Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Gene Delivery System Technology Drug Market Size (2021-2032)
  8. 1.5.1 North America Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Gene Delivery System Technology Drug Market Size Growth Rate (2021-2032)
2 Gene Delivery System Technology Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Viral Gene Delivery System
  3. 2.1.2 Non-viral Gene Delivery System
  4. 2.2 Global Gene Delivery System Technology Drug Market Size by Type
  5. 2.2.1 Global Gene Delivery System Technology Drug Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Gene Delivery System Technology Drug Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Gene Delivery System Technology Drug Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Gene Delivery System Technology Drug Market Size by Regions
  9. 2.3.1 North America Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Gene Delivery System Technology Drug Market Size Breakdown by Type (2021-2026)
3 Gene Delivery System Technology Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Neurological Diseases
  3. 3.1.2 Cancer
  4. 3.1.3 Other
  5. 3.2 Global Gene Delivery System Technology Drug Market Size by Application
  6. 3.2.1 Global Gene Delivery System Technology Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Gene Delivery System Technology Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Gene Delivery System Technology Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Gene Delivery System Technology Drug Market Size by Regions
  10. 3.3.1 North America Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Gene Delivery System Technology Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Gene Delivery System Technology Drug Industry Trends
  2. 4.2 Gene Delivery System Technology Drug Industry Drivers
  3. 4.3 Gene Delivery System Technology Drug Industry Opportunities and Challenges
  4. 4.4 Gene Delivery System Technology Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Gene Delivery System Technology Drug Revenue (2021-2026)
  2. 5.2 Global Gene Delivery System Technology Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Gene Delivery System Technology Drug Key Company Headquarters & Area Served
  4. 5.4 Global Gene Delivery System Technology Drug Company, Product Type & Application
  5. 5.5 Global Gene Delivery System Technology Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Gene Delivery System Technology Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Gene Delivery System Technology Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Gene Delivery System Technology Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Akcea Therapeutics
  2. 6.1.1 Akcea Therapeutics Company Information
  3. 6.1.2 Akcea Therapeutics Business Overview
  4. 6.1.3 Akcea Therapeutics Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Akcea Therapeutics Gene Delivery System Technology Drug Product Portfolio
  6. 6.1.5 Akcea Therapeutics Recent Developments
  7. 6.2 Alnylam Pharmaceuticals
  8. 6.2.1 Alnylam Pharmaceuticals Company Information
  9. 6.2.2 Alnylam Pharmaceuticals Business Overview
  10. 6.2.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product Portfolio
  12. 6.2.5 Alnylam Pharmaceuticals Recent Developments
  13. 6.3 AnGes
  14. 6.3.1 AnGes Company Information
  15. 6.3.2 AnGes Business Overview
  16. 6.3.3 AnGes Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AnGes Gene Delivery System Technology Drug Product Portfolio
  18. 6.3.5 AnGes Recent Developments
  19. 6.4 bluebird bio
  20. 6.4.1 bluebird bio Company Information
  21. 6.4.2 bluebird bio Business Overview
  22. 6.4.3 bluebird bio Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 bluebird bio Gene Delivery System Technology Drug Product Portfolio
  24. 6.4.5 bluebird bio Recent Developments
  25. 6.5 Gilead Sciences
  26. 6.5.1 Gilead Sciences Company Information
  27. 6.5.2 Gilead Sciences Business Overview
  28. 6.5.3 Gilead Sciences Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Gilead Sciences Gene Delivery System Technology Drug Product Portfolio
  30. 6.5.5 Gilead Sciences Recent Developments
  31. 6.6 Human Stem Cells Institute
  32. 6.6.1 Human Stem Cells Institute Company Information
  33. 6.6.2 Human Stem Cells Institute Business Overview
  34. 6.6.3 Human Stem Cells Institute Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Human Stem Cells Institute Gene Delivery System Technology Drug Product Portfolio
  36. 6.6.5 Human Stem Cells Institute Recent Developments
  37. 6.7 Orchard Therapeutics
  38. 6.7.1 Orchard Therapeutics Company Information
  39. 6.7.2 Orchard Therapeutics Business Overview
  40. 6.7.3 Orchard Therapeutics Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Orchard Therapeutics Gene Delivery System Technology Drug Product Portfolio
  42. 6.7.5 Orchard Therapeutics Recent Developments
  43. 6.8 Sarepta Therapeutics
  44. 6.8.1 Sarepta Therapeutics Company Information
  45. 6.8.2 Sarepta Therapeutics Business Overview
  46. 6.8.3 Sarepta Therapeutics Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sarepta Therapeutics Gene Delivery System Technology Drug Product Portfolio
  48. 6.8.5 Sarepta Therapeutics Recent Developments
  49. 6.9 SIBIONO
  50. 6.9.1 SIBIONO Company Information
  51. 6.9.2 SIBIONO Business Overview
  52. 6.9.3 SIBIONO Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 SIBIONO Gene Delivery System Technology Drug Product Portfolio
  54. 6.9.5 SIBIONO Recent Developments
  55. 6.10 Spark Therapeutics
  56. 6.10.1 Spark Therapeutics Company Information
  57. 6.10.2 Spark Therapeutics Business Overview
  58. 6.10.3 Spark Therapeutics Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Spark Therapeutics Gene Delivery System Technology Drug Product Portfolio
  60. 6.10.5 Spark Therapeutics Recent Developments
  61. 6.11 Sunway Biotech
  62. 6.11.1 Sunway Biotech Company Information
  63. 6.11.2 Sunway Biotech Business Overview
  64. 6.11.3 Sunway Biotech Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sunway Biotech Gene Delivery System Technology Drug Product Portfolio
  66. 6.11.5 Sunway Biotech Recent Developments
  67. 6.12 Amgen
  68. 6.12.1 Amgen Company Information
  69. 6.12.2 Amgen Business Overview
  70. 6.12.3 Amgen Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Amgen Gene Delivery System Technology Drug Product Portfolio
  72. 6.12.5 Amgen Recent Developments
  73. 6.13 Biogen
  74. 6.13.1 Biogen Company Information
  75. 6.13.2 Biogen Business Overview
  76. 6.13.3 Biogen Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Biogen Gene Delivery System Technology Drug Product Portfolio
  78. 6.13.5 Biogen Recent Developments
  79. 6.14 Novartis
  80. 6.14.1 Novartis Company Information
  81. 6.14.2 Novartis Business Overview
  82. 6.14.3 Novartis Gene Delivery System Technology Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Novartis Gene Delivery System Technology Drug Product Portfolio
  84. 6.14.5 Novartis Recent Developments
7 North America
  1. 7.1 North America Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Gene Delivery System Technology Drug Market Size by Country (2021-2026)
  3. 7.3 North America Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Gene Delivery System Technology Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Gene Delivery System Technology Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Gene Delivery System Technology Drug Market Size by Country (2021-2026)
  3. 10.3 South America Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Gene Delivery System Technology Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst